Incidence of clinician-diagnosed lyme disease, United States, 2005–2010

Emerging Infectious Diseases

Volumn 21, Issue 9, 2015, Pages 1625-1631

  Nelson, Christina A ^a   Saha, Shubhayu ^a   Kugeler, Kiersten J ^a   Delorey, Mark J ^a   Shankar, Manjunath B ^a   Hinckley, Alison F ^a   Mead, Paul S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; RETROSPECTIVE STUDY; UNITED STATES; AGED; AMBULATORY CARE; COMMUNICABLE DISEASES, EMERGING; HEALTH SURVEY; OUTPATIENT; PRESCHOOL CHILD; SEASON; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMANS; INCIDENCE; LYME DISEASE; MALE; MIDDLE AGED; OFFICE VISITS; OUTPATIENTS; PUBLIC HEALTH SURVEILLANCE; SEASONS; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84939479898     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2109.150417     Document Type: Article

References (28)

1. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med. 2003; 348:2472-4. http://dx.doi.org/10.1056/NEJM200306123482423
2. Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med. 2002;136:421-8. http://dx.doi.org/10.7326/0003-4819-136-6-200203190-00005
3. Centers for Disease Control and Prevention. Three sudden cardiac deaths associated with Lyme carditis-United States, November 2012-July 2013. MMWR Morb Mortal Wkly Rep. 2013;62:993-6.
4. Halperin JJ. Nervous system Lyme disease. Handb Clin Neurol. 2014;121:1473-83. http://dx.doi.org/10.1016/B978-0-7020-4088-7.00099-7
5. Rothermel H, Hedges TR, Steere AC. Optic neuropathy in children with Lyme disease. Pediatrics. 2001;108:477-81. http://dx.doi.org/ 10.1542/peds.108.2.477
6. Centers for Disease Control and Prevention. Final 2013 reports of nationally notifiable infectious diseases. MMWR Morb Mortal Wkly Rep. 2014;63:702.
7. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ. 2008;57:1-9.
8. Janes G, Hutwagner L, Cates W, Stroup D, Williamson G. Principles and practices of public health surveillance. 2nd ed. New York: Oxford University Press; 2000.
9. Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP. Estimation of the incidence of Lyme disease. Am J Epidemiol. 1998;148:1018-26. http://dx.doi.org/10.1093/oxfordjournals.aje.a009568
10. Coyle BS, Strickland GT, Liang YY, Pena C, McCarter R, Israel E. The public health impact of Lyme disease in Maryland. J Infect Dis. 1996;173:1260-2. http://dx.doi.org/10.1093/infdis/173.5.1260
11. Meek JI, Roberts CL, Smith EV, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract. 1996;2:61-5. http://dx.doi.org/10.1097/00124784-199623000-00017
12. Naleway AL, Belongia EA, Kazmierczak JJ, Greenlee RT, Davis JP. Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohort. Am J Epidemiol. 2002;155:1120-7. http://dx.doi.org/10.1093/aje/155.12.1120
13. Wormser GP, Dattwyler R, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134. http://dx.doi.org/10.1086/508667
14. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, Sharp P, Anderson WJ, et al. Summary of notifiable diseases-United States, 2011. MMWR Morb Mortal Wkly Rep. 2013;60:1-117.
15. National Notifiable Diseases Surveillance System. Lyme disease case definitions, 1995-2011 [cited 2015 Jun 28]. http://wwwn.cdc.gov/nndss/conditions/lyme-disease/
16. US Census Bureau. 2010 Census demographic profile summary file. 2011 [cited 2015 Jun 26]. http://www.census.gov/2010census/data
17. Kim SY, Solomon DH, Liu J, Chang CL, Daniel GW, Schneeweiss S. Accuracy of identifying neutropenia diagnoses in outpatient claims data. Pharmacoepidemiol Drug Saf. 2011;20:709-13. http://dx.doi.org/10.1002/pds.2157
18. Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol. 2004;75:12-7. http://dx.doi.org/10.1002/ajh.10445
19. Sickbert-Bennett EE, Weber DJ, Poole C, MacDonald PD, Maillard JM. Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. Am J Epidemiol. 2010;172:1299-305. http://dx.doi.org/10.1093/aje/kwq285
20. Rutz H, Hinckley A, Hogan B, Feldman K. Exploring the use of diagnostic codes as an alternative approach to Lyme disease surveillance in Maryland. 23rd Annual Conference of the Council of State and Territorial Epidemiologists: 2013 Jun 9-13; Pasadena (CA) [cited 2015 Jun 26]. https://cste.confex.com/cste/2013/webprogram/Paper1901.html
21. Clayton JL, Jones SG, Dunn JR, Schaffner W, Jones TF. Enhancing Lyme disease surveillance by using administrative claims data, Tennessee, USA. Emerg Infect Dis. 2015;21:1632-1634.
22. Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, Feldman KA, et al. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59:676-81. http://dx.doi.org/10.1093/cid/ ciu397
23. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461-73. http://dx.doi.org/10.1016/ S0140-6736(11)60103-7
24. Miralles D, Hartman B, Brause B, Fisher L, Murray HW. Not everything that glitters is Lyme disease. Am J Med. 1992;93:352-3. http://dx.doi.org/10.1016/0002-9343(92)90248-A
25. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993;269:1812-6. http://dx.doi.org/ 10.1001/jama.1993.03500140064037
26. Robinson S. Lyme disease in Maine: a comparison of NEDSS surveillance data and Maine Health Data Organization hospital discharge data. Online J Public Health Inform. 2014;5:231. http://dx.doi.org/10.5210/ojphi.v5i3.4990
27. Bennet L, Stjernberg L, Berglund J. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoonotic Dis. 2007;7:34-41. http://dx.doi.org/ 10.1089/vbz.2006.0533
28. Strle F, Wormser GP, Mead P, Dhaduvai K, Longo MV, Adenikinju O, et al. Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS ONE. 2013;8:e64110. http://dx.doi.org/10.1371/journal. pone.0064110